At the international IAS Conference on HIV Science (Inactive account) on HIV Science, WHO launched 🆕 guidelines on #HIV for prevention, treatment, monitoring & service delivery, including important updates & recommendations since 2016. More in detail 👉bit.ly/3wLxPbA #IAS2021

People like you are #ChangingHIVCare right now. Share how you think we can redefine health related quality of life in the future of HIV care and join our community event ‘Unlocking our Common Health: Reflections on IAS’ on 27th July to hear more. ms.spr.ly/6004njfks

#IAS2021 final words from Adeeba Kamarulzaman "let's reunite in Montreal & virtually for #IAS2022" What a meeting! Thank you IAS Conference on HIV Science (Inactive account) team, presenters, attendees, sponsors & the people living with, or at risk of, HIV who contributed to all the invaluable research. YOU ALL ROCK!

It's been a pleasure and an absolute honour being a rapporteur for #IAS2021! See you in Montreal at #AIDS2022!

It was four amazing days at #IAS2021 I had a great pleasure to present my work to a global audience in an engaging scientific environment. Lets continue to follow the science and make sure that new scientific findings are put into practice to save lives. See you all in Montreal!

That's a wrap from the stellar #IAS2021, with a heartfelt performance from SF Gay Men's Chorus! Thank you to IAS Conference on HIV Science (Inactive account) IAS - the International AIDS Society conference co-chair Adeeba Kamarulzaman Hendrik Streeck. Can't wait till we meet again in Montreal for #AIDS2022.

Join Prof @profchloeorkin.bsky.social on July 22nd as she will provide a rapid update from #IAS2021 and answer your questions in a live, interactive, CME/CE-certified webinar. 𝗥𝗘𝗚𝗜𝗦𝗧𝗘𝗥 𝗡𝗢𝗪➡️bit.ly/36VjZZP #IDTwitter #MedTwitter #HIV #PrEP IAS Conference on HIV Science (Inactive account) IAS - the International AIDS Society

News from the IAS Conference on HIV Science (Inactive account): Multiple African countries improved access to HIV treatment during #COVID19 pandemic #IAS2021

🔬[#IAS2021]🎗 Dernier compte rendu de la 11e édition de l’#IAS, qui s’est conclue hier avec un discours militant et inspirant. @Seronet dresse le bilan de ces 4 jours de conférences scientifiques 👇 urlr.me/4tysw

Notizie da IAS 2021: Trattamento precoce e conte CD4 più elevate associati a una riduzione dei reservoir HIV, Giovedì 22 luglio 2021 #IAS2021 aidsmap.com/node/34821/pre…

Join Prof. Babafemi Taiwo Babafemi Olapoju Taiwo on July 23rd as he will provide a rapid update from #IAS2021 and answer your questions in a live, interactive, CME/CE-certified webinar. 𝗥𝗘𝗚𝗜𝗦𝗧𝗘𝗥 𝗡𝗢𝗪➡️bit.ly/3rAtJ51 #IDTwitter #MedTwitter #HIV IAS Conference on HIV Science (Inactive account) aidsmap

Long-acting drug lenacapavir shows sustained viral suppression in drug resistant HIV at 26 weeks. ms.spr.ly/6019ngjDP #IAS2021

What Will Bring People Living With HIV Back Into Care? @HeatherBoerner poz.com/article/will-b… #AfricanAmerican #UequalsU #IAS2021

Phelister Abdalla ist #HIV-positiv, Mutter dreier Kinder, Sexarbeiterin und nationale Koordinatorin der KESWA. Auf dem #IAS2021 berichtet Abdalla, wie und warum sich der Blick auf #Sexarbeit dringend ändern muss. bit.ly/2V33IPC IAS Conference on HIV Science (Inactive account) IAS - the International AIDS Society

Globally, trans women are 49 x more likely to have HIV than general population. It’s vital their HIV prevention and support needs are met. Some good news - gender affirming hormone therapy doesn’t affect #PrEP, nor PrEP affect GAHT levels. #IAS2021 aidsmap.com/news/jul-2021/…

All oral abstracts from #IAS2021 are now available! Access all abstracts for free via the Journal of the IAS IAS 2021 Special Issue: ow.ly/bGPg30rOJiK